| 000 | 01036 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513134607.0 | ||
| 264 | 0 | _c19980320 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0307-7772 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSrinivasan, V | |
| 245 | 0 | 0 |
_aWarfarin and epistaxis: should warfarin always be discontinued? _h[electronic resource] |
| 260 |
_bClinical otolaryngology and allied sciences _cDec 1997 |
||
| 300 |
_a542-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aEpistaxis _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 700 | 1 | _aPatel, H | |
| 700 | 1 | _aJohn, D G | |
| 700 | 1 | _aWorsley, A | |
| 773 | 0 |
_tClinical otolaryngology and allied sciences _gvol. 22 _gno. 6 _gp. 542-4 |
|
| 999 |
_c9435030 _d9435030 |
||